Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Mettler-Toledo International's 10-Year RORE % for the quarter that ended in Mar. 2026 was 8.60%.
FRA:MTO's 10-Year RORE % is ranked better than 66.12% of 121
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.55
vs FRA:MTO: 8.60
Mettler-Toledo International (FRA:MTO) 10-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Mettler-Toledo International 10-Year RORE % Related Terms
Mettler-Toledo International 10-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MTO vs ILMN, DGX, LH: 10-Year RORE % Comparison
For the Diagnostics & Research subindustry, Mettler-Toledo International's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mettler-Toledo International 10-Year RORE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where Mettler-Toledo International's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.
Mettler-Toledo International (FRA:MTO) has a 10-Year RORE % of 8.60 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Mettler-Toledo International and its competitors. According to the industry distribution chart, Mettler-Toledo International ranks #41 out of 121 companies in the Medical Diagnostics & Research industry, placing it in the top 33.9%.
Is Mettler-Toledo International's 10-Year RORE % too high?
Mettler-Toledo International's current 10-Year RORE % is 8.60. The Medical Diagnostics & Research industry median 10-Year RORE % is 1.55. Mettler-Toledo International's value of 8.60 is 454.8% above this industry median. Based on the distribution chart, Mettler-Toledo International ranks #41 out of 121 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Mettler-Toledo International has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's 10-Year RORE % compare to ILMN and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #41 out of 121 companies for 10-Year RORE %. This puts Mettler-Toledo International in the upper half of its industry. The industry median 10-Year RORE % is 1.55. Mettler-Toledo International's value of 8.60 is 454.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Medical Diagnostics & Research company?
The median 10-Year RORE % among Medical Diagnostics & Research companies is 1.55, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mettler-Toledo International's current 10-Year RORE % of 8.60 is 454.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Mettler-Toledo International and its competitors. For the Medical Diagnostics & Research industry, the median 10-Year RORE % is 1.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mettler-Toledo International's current 10-Year RORE % is 8.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Based on GuruFocus' analysis, Mettler-Toledo International (FRA:MTO) is currently considered Modestly Undervalued. The stock's GF Value™ is €1,297.94, compared to a current price of €1,130.00 — trading 12.9% below its estimated fair value. The current 10-Year RORE % is 8.60 and 454.8% above the Medical Diagnostics & Research industry median of 1.55. Mettler-Toledo International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current 10-Year RORE % is 8.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of €1,130.00 is trading 12.9% below its estimated GF Value™ of €1,297.94.
GuruFocus considers Mettler-Toledo International to be Modestly Undervalued.
Key valuation signals for FRA:MTO:
10-Year RORE %: 8.60
GF Value™: €1,297.94 vs. price of €1,130.00 (12.9% below fair value)
Industry Position: 454.8% above the Medical Diagnostics & Research median (#41 of 121)
No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
92GF Score
Get the complete analysis for FRA:MTO
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MTO has been successfully added to your 
